Search Results 141-150 of 13318 for Pancreatic cancer red flag
... pancreas, pancreatitis, morphs into pancreatic cancer. ... MULTIMEDIA ALERT: For audio and video of Geou-Yarh Liou, Ph. ... pancreas — those that produce ...
The most common genetic mutation was in the BRCA2 gene, known as a "breast cancer gene." "We found that the patients who had one of these genetic mutations — ...
The purpose of this study is to prospectively validate a computational pathology-based risk model using spatial metrics derived from resected PDAC specimens ...
Researchers in Mayo Clinic's Gastrointestinal Cancer Program study new diagnostic tools, treatments and approaches to prevention of pancreatic cancer. They are ...
The High-Risk Pancreatic Cancer Program in Arizona offers multidisciplinary screening and management using advanced technology and integrated care.
It causes permanent damage and scarring of the pancreas. Chronic pancreatitis can lead to weight loss, pain, diabetes and pancreatic cancer. Chronic ...
A phase 2 trial shows that a new drug doubles one-year survival in patients with metastatic pancreatic cancer.
The purpose of this study is to assess DNA markers in pancreatic juice and stool for the detection of pancreatic cancer and precancer. Participation eligibility.
... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...
Learn about metastatic (stage 4) pancreatic cancer, including symptoms, causes, diagnosis and treatment options.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.